Based on current data, GLP-1s appear generally well tolerated in people with IBD, but we do not yet have large, long-term trials in people with UC, so I tell patients we should decide together, case by case, based on their disease activity, nutritional status, and other health conditions, Dr
Dietary adherence was also not objectively quantified using validated assessment tools, and differential compliance between groups may have contributed to variations in weight-related outcomes
IM or subcutaneous injections may cause mild temporary soreness at the injection site
Scientific References Ozempic 0.5 mg solution for injection in pre-filled pen
According to the findings, 36% of current GLP-1 users report currently microdosing, 32% of users say they used to microdose in the past, but have stopped, and 32% say they have never microdosed